Filing Details

Accession Number:
0001457612-22-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-26 16:11:58
Reporting Period:
2022-05-26
Accepted Time:
2022-05-26 16:11:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Biological Products, (No Disgnostic Substances) (2836) 510596811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1696784 Diantha Duvall C/O Genocea Biosciences, Inc.
100 Acorn Park Drive, 5Th Floor
Cambridge MA 02140
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-26 24,407 $0.08 76,743 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.0765 to $0.0766, inclusive.